Increased levels of the antibody immunoglobulin A (IgA) are correlated with the manifestation of several diseases and African ancestry, according to findings published in Nature Communications.
Browsing: Disease Discoveries
Northwestern Medicine scientists have identified a new therapeutic target against tumor cells and developed a compound which slows tumor growth and bolsters immune response.
Northwestern Medicine scientists have identified pathogenic variants in two genes linked to microcephaly and other neurodevelopmental disorders in children, according to a recent study published in Nature Communications.
A new Northwestern Medicine study has discovered the role of cerebrospinal fluid in cognitive impairment, such as Alzheimer’s disease.
Medical students and disability advocates gathered at the second Disability Advocacy Coalition in Medicine Interprofessional Virtual Conference to address ableism in medicine and medical education.
Investigators have identified previously unknown sets of epigenetic changes in pediatric brain tumors, which could serve as novel therapeutic targets and provide alternative treatment options.
The presence of food-specific IgA antibodies in the gut does not prevent peanut or egg allergies from developing in children, according to a Northwestern Medicine-led study published in Science Translational Medicine.
Genetic testing in epilepsy patients can inform treatment and lead to better outcomes in many cases, according to a study published in JAMA Neurology.
Northwestern Medicine investigators continue to study the impact of the COVID-19 pandemic on health outcomes and society, from maternal vaccinations and antibody response to reducing burnout amongst healthcare workers and identifying novel therapeutic targets.
A study led by Northwestern Medicine investigators found that education and place of birth significantly contribute to racial and ethnic differences in cardiovascular health among U.S. adults.